Xueliang Fan Selected Research

Dystonic Disorders (Writer's Cramp)

1/2021	Differential expression of striatal proteins in a mouse model of DOPA-responsive dystonia reveals shared mechanisms among dystonic disorders.
10/2015	A new knock-in mouse model of l-DOPA-responsive dystonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xueliang Fan Research Topics

Disease

11	Dystonia (Limb Dystonia) 01/2023 - 01/2006
3	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2012 - 04/2007
2	Parkinson Disease (Parkinson's Disease) 01/2023 - 07/2014
2	Dopa-responsive Dystonia 01/2023 - 01/2021
2	Parkinsonian Disorders (Parkinsonism) 01/2023 - 12/2017
2	Dystonic Disorders (Writer's Cramp) 01/2021 - 10/2015
2	Dystonia musculorum deformans type 1 01/2019 - 10/2012
2	Coloboma (Colobomas) 01/2010 - 04/2007
1	Movement Disorders (Movement Disorder) 01/2023
1	Dyskinesias (Dyskinesia) 10/2015
1	Type 2 Episodic Ataxia 11/2014
1	Ataxia (Dyssynergia) 11/2014
1	Atrophy 10/2012
1	Paroxysmal nonkinesigenic dyskinesia 02/2012

Drug/Important Bio-Agent (IBA)

12	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 04/2007
4	Dopamine Receptors (Dopamine Receptor)IBA 01/2023 - 04/2007
4	Dopamine Agonists (Dopamine Agonist)IBA 01/2023 - 10/2015
3	Dopamine AntagonistsIBA 01/2023 - 04/2007
3	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 10/2015
3	Amphetamine (Amfetamine)FDA LinkGeneric 10/2012 - 04/2007
2	RacloprideIBA 01/2023 - 04/2007
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2012
2	Trihexyphenidyl (Artane)FDA LinkGeneric 01/2019 - 10/2015
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Dihydroxyphenylalanine (Dopa)IBA 01/2019
1	Cholinergic Agents (Cholinergics)IBA 01/2019
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2019
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2019
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2019
1	Dopamine Agents (Dopaminergic Agents)IBA 01/2018
1	Caffeine (No Doz)FDA LinkGeneric 11/2014
1	Ethanol (Ethyl Alcohol)IBA 11/2014
1	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 07/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 07/2014
1	Codon (Codons)IBA 10/2012
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2012
1	AcidsIBA 03/2012
1	PicrotoxinIBA 03/2012
1	Glutamate Receptors (Glutamate Receptor)IBA 03/2012
1	AMPA Receptors (AMPA Receptor)IBA 03/2012
1	Glutamic Acid (Glutamate)FDA Link 03/2012
1	Serotonin (5 Hydroxytryptamine)IBA 01/2012
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2012
1	Calcium Channels (Calcium Channel)IBA 09/2008
1	Kainic Acid (Kainate)IBA 09/2008
1	Haloperidol (Haldol)FDA LinkGeneric 04/2007
1	SCH 23390IBA 04/2007
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 01/2006

Therapy/Procedure

2	Therapeutics 01/2010 - 04/2007